Diagnostics lab joins Waters’ innovation program

Skip to Navigation

Blog Post

  • Published: Mar 21, 2016
  • Author: Jon Evans
  • Source: Waters Corporation
  • Suppliers: Waters Corporation
  • Channels: Ion Chromatography / Laboratory Informatics / Sample Preparation / Proteomics & Genomics / HPLC / Detectors / Electrophoresis / Gas Chromatography / Raman / Infrared Spectroscopy / Proteomics / NMR Knowledge Base / Atomic / MRI Spectroscopy / Base Peak / UV/Vis Spectroscopy / Chemometrics & Informatics / X-ray Spectrometry

View comments on this post

Waters Corporation has inaugurated the University of California, San Diego’s Center for Advanced Laboratory Medicine into the Waters Centers of Innovation (COI) Program.

Under the direction of Robert Fitzgerald, director of toxicology and associate director of clinical chemistry, the laboratory develops, validates and implements liquid chromatography-mass spectrometry (LC-MS) diagnostic tests, including broad spectrum screens for drugs of abuse, therapeutic drug monitoring and vitamin D testing.

“We are very excited that Waters Corporation has recognized our department’s work in developing mass spectrometry-based tests for the clinical laboratory,” said Steven Gonias, chair of the Department of Pathology in the UC San Diego School of Medicine and chief of pathology at UC San Diego Health. “Dr Fitzgerald and Dr David Herold of the UC San Diego School of Medicine have contributed landmark studies focused on improving the accuracy of diagnostic tests by applying mass spectrometry in new and innovative ways. The potential to further improve patient care through the expanded use of mass spectrometry is indeed impressive.”

Fitzgerald is one of the world’s foremost experts in the use of mass spectrometry for the analysis of testosterone and other biologically important compounds. His laboratory is also a major research center for studying cardiac biomarkers that can be used to diagnose disease and monitor therapeutic interventions. In his role, Fitzgerald oversees the activities of three clinical laboratories for UC San Diego Health, which together perform more than 4.5 million assays annually. Fitzgerald’s laboratory utilizes several Waters tandem quadrupole and quadrupole time of flight mass spectrometers, including the Xevo TQ-S, Xevo G2 QTof and ACQUITY TQD.

“Waters has been an outstanding partner for us and has fully supported us with robust instrumentation and solid technical support,” Fitzgerald said. “I am particularly excited about the aspect of our collaboration with Waters that allows us to train the next generation of leaders in clinical chemistry, a field in which mass spectrometry is becoming increasingly important.”

“It’s a pleasure to welcome the UC San Diego School of Medicine into our COI Program. Largely due to the efforts of scientists like Dr Fitzgerald and his colleagues, the value of LC and MS in the clinical laboratory has been clearly proven and is having lasting benefits in the clinic,” said Eric Fotheringham, director of the Waters Centers of Innovation Program.

(Photo of Robert Fitzgerald courtesy of UC San Diego.)


There are currently no comments on this post.

Comment Form

You have to log in to comment on this post.

Log in using the form at the top of the page or register here.

Social Links

Share This Links

Bookmark and Share


Suppliers Selection
Societies Selection

Banner Ad

Click here to see
all job opportunities

Most Viewed

Copyright Information

Interested in spectroscopy? Visit our sister site spectroscopyNOW.com

Copyright © 2020 John Wiley & Sons, Inc. All Rights Reserved